Diseases & Conditions market research reports by DelveInsight

• Lumbar Facet Joint Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Lumbar Facet Joint Pain - Pipeline Insight, 2024 Lumbar Facet Joint Pain Overview ""Lumbar Facet Joint Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Lumbar Facet Joint Pain market. A detail ... Read More

• Anemia Associated with Chronic Kidney - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anemia Associated with Chronic Kidney - Pipeline Insight, 2024 Anemia Associated with Chronic Kidney Overview ""Anemia Associated with Chronic Kidney Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ... Read More

• Multiple sclerosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Multiple sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Multiple sclerosis - Pipeline Insight, 2024,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncli ... Read More

• CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma pipeline ... Read More

• Sleep Apnea - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Sleep Apnea - Pipeline Insight, 2024 Sleep Apnea Overview ""Sleep Apnea Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Sleep Apnea market. A detailed picture of the Sleep Apnea pipeline landscape ... Read More

• Cutaneous Lupus Erythematosus – Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Cutaneous Lupus Erythematosus – Pipeline Insight, 2024 DelveInsight’s, “Cutaneous Lupus Erythematosus – Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the pipeline drug profiles ... Read More

• Thymus Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Thymus Cancer - Pipeline Insight, 2024 Thymus Cancer Overview ""Thymus Cancer Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Thymus Cancer market. A detailed picture of the Thymus Cancer pipeline ... Read More

• Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024 Undifferentiated Pleomorphic Sarcoma (UPS) Overview ""Undifferentiated Pleomorphic Sarcoma (UPS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth pros ... Read More

• Cutaneous Lupus Erythematosus- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Cutaneous Lupus Erythematosus- Pipeline Insight, 2024 DelveInsight’s, “ Cutaneous Lupus Erythematosus- Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the pipeline drug profiles, ... Read More

• Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024 Relapsing Multiple Sclerosis (RMS) Overview ""Relapsing Multiple Sclerosis (RMS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Relapsi ... Read More

• Chronic Lower Back Pain (CLBP) - Epidemiology Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Chronic Lower Back Pain (CLBP) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that the total diagnosed prevalent of Chronic Lower Back Pain cases in 7MM were approximately 67 million in 2022 and these cases are going to increase because of changes in psychosocial and p ... Read More

• Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024 Acquired Immunodeficiency Syndrome (AIDS) Overview ""Acquired Immunodeficiency Syndrome (AIDS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospec ... Read More

• Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024 Acute Myelogenous Leukemia (AML) Overview ""Acute Myelogenous Leukemia (AML) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Myeloge ... Read More

• Pemphigus Vulgaris - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Pemphigus Vulgaris - Pipeline Insight, 2024 DelveInsight’s, “Pemphigus Vulgaris (PV) – Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pemphigus Vulgaris pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Zika virus infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Zika virus infection - Pipeline Insight, 2024 DelveInsight’s, “Zika Virus Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Zika Virus Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

• Dengue- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Dengue- Pipeline Insight, 2024 DelveInsight’s, “Dengue- Pipeline Insight, 2024,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More

• Gouty Arthritis (Gout) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Gouty Arthritis (Gout) - Pipeline Insight, 2024 DelveInsight’s, “Gout - Pipeline Insight, 2024,” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Gout pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It a ... Read More

• Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Juvenile Rheumatoid Arthritis – Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Juvenile Rheumatoid Arthritis pipeline landscape. It covers the pipeline drug profiles ... Read More

• Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024 Advanced Cancer Pain Management (ACPM) Overview ""Advanced Cancer Pain Management (ACPM) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

• Erosive Hand Osteoarthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Erosive Hand Osteoarthritis - Pipeline Insight, 2024 Erosive Hand Osteoarthritis Overview ""Erosive Hand Osteoarthritis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Erosive Hand Osteoarthritis ... Read More

• Knee osteoarthritis – Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Knee osteoarthritis – Pipeline Insight, 2024 DelveInsight’s, “Knee osteoarthritis – Pipeline Insight, 2024,” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Knee osteoarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024 Juvenile Idiopathic arthritis (JIA) Overview ""Juvenile Idiopathic arthritis (JIA) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Juve ... Read More

• Cannabidiol (CBD) Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Cannabidiol (CBD) Pain - Pipeline Insight, 2024 Cannabidiol (CBD) Pain Overview ""Cannabidiol (CBD) Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cannabidiol (CBD) Pain market. A detailed p ... Read More

• Polyarticular Juvenile Idiopathic Arthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Polyarticular Juvenile Idiopathic Arthritis - Pipeline Insight, 2024 Polyarticular Juvenile Idiopathic Arthritis Overview ""Polyarticular Juvenile Idiopathic Arthritis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth p ... Read More

• Axial spondyloarthritis (axSpA) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Axial spondyloarthritis (axSpA) - Pipeline Insight, 2024 DelveInsight’s, “Axial spondyloarthritis (axSpA) - Pipeline Insight, 2024” report provides comprehensive insights about 15+companies and 15+pipeline drugs in Axial spondyloarthritis (axSpA) pipeline landscape. It covers the pipeline drug profi ... Read More

< prev 12 13 14 15 16 17 18 19 20 21 next >